Trametinib With GSK2141795 in BRAF Wild-type Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01941927
Recruitment Status : Unknown
Verified February 2015 by Adil Daud, University of California, San Francisco.
Recruitment status was:  Active, not recruiting
First Posted : September 13, 2013
Last Update Posted : February 19, 2015
National Comprehensive Cancer Network
Information provided by (Responsible Party):
Adil Daud, University of California, San Francisco

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Unknown
  Actual Primary Completion Date : December 2014
  Estimated Study Completion Date : May 2016

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 February 28, 2018
March 27, 2018
2 May 4, 2018
June 6, 2018
3 June 8, 2018
June 11, 2018